Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
Go back to Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab| (NASDAQ: TLSA) | Delayed: 1.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.15 | 52 Week High | $ | |||
| Open | $1.15 | 52 Week Low | $ | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.15 | EPS | $ | |||
| Volume | 30 | |||||
